Subgroup analysis of different genotyping methods (Taqman, MALDI-TOF, no PCR-restriction fragment length polymorphism (PCR-RFLP) for only one study) showed no relationship between ERCC1 rs11615 and breast cancer risk, when including the studies that were deviant from HWE or not. Here, ERCC1 is linked to breast carcinoma.